Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An X-linked recessive retinal disease characterized by fundus hypopigmentation, decrased visual acuity, nystagmus, astigmatism, progressive axial myopia, defective dark adaptation and protanopia.
Features include always present findings: Astigmatism, Severely reduced visual acuity, Hypoplasia of the fovea, and Hypopigmentation of the fundus and others; and very common findings: Abnormal electroretinogram, Color vision defect, Reduced visual acuity, and Difficulty adjusting from light to dark. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Nystagmus, Color vision defect |
X-linked congenital stationary night blindness (CSNB) is a congenital non-progressive retinal disorder characterized by defective night vision, reduced visual acuity, myopia, nystagmus, and strabismus that primarily affects males.
Reduced visual acuity. Vision is reduced in all affected males in the range of 20/30 (6/9; log MAR 0.1) to 20/200 (6/60; log MAR 1.0). Defective dark adaptation. Night blindness is a subjective finding. Individuals with NYX X-linked CSNB generally report severe night blindness. Individuals with CACNA1F X-linked CSNB do not uniformly report severe night blindness. Myopia may range from low (-0.25 diopters [D] to -4.75 D) to high (≥ -10.00 D) . A few affected individuals have hyperopia. Nystagmus and strabismus are reported in 50%-70% of affected individuals .
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
CACNA1F encodes calcium voltage-gated channel subunit alpha1 F (1,977 aa). Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. Highest expression in Small Intestine Terminal Ileum (2.5 TPM) and Brain Cerebellar Hemisphere (2.2 TPM).
Aland island eye disease is associated with mutations in the CACNA1F gene on chromosome X.
CACNA1F is classified as a druggable target (Druggable Genome and Ion Channel categories) with score 1.2.
No genotype-phenotype correlations are known.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Penetrance of X-linked CSNB is probably 100%, but expressivity is variable ; individuals with mild presentations may be missed if electroretinography is not performed.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Suggestive Findings Males. X-linked congenital stationary night blindness (CSNB) should be suspected in a male proband with the following characteristic clinical and electroretinogram (ERG) findings characteristicec of complete X-linked CSNB or incomplete X-linked CSNB : Characteristic clinical findings: • Reduced visual acuity • Night blindness • Myopia • Nystagmus (not universal) and strabismus (50%-70%) • Normal color vision • Normal fundus examination • Family history consistent with X-linked inheritance Characteristic findings on ERG examination: • ERG is used to assess the changes in electrical activity of the retina in response to light. The b-wave is caused by the depolarization of ON bipolar cells in response to light stimuli and is strictly dependent on synaptic transmission from photoreceptors to ON bipolar cells. • Individuals with X-linked CSNB have reduced scotopic b-wave amplitudes in response to bright flashes after dark adaptation. The resulting ERG waveform is essentially a negative wave (amplitude of the a-wave is larger than the b-wave, not reaching the baseline) , referred to as the Schubert-Bornschein form . • The ERG can define specific retinal dysfunctions and, in general, differentiate the forms of X-linked CSNB, thereby identifying the gene most likely to be involved . Table 1. Electroretinogram Findings in Complete and Incomplete X-Linked Congenital Stationary Night Blindness
ERG Finding | Complete (NYX X-linked CSNB) | Incomplete (CACNA1F X-linked CSNB) |
|---|---|---|
Scotopic rod b-wave | Severely reduced or absent | Reduced |
Mixed scotopic a-wave | Normal | Slightly reduced |
Mixed scotopic b-wave | Reduced | Reduced |
Scotopic OP | Absent | Slightly reduced |
Photopic a-wave | Normal, slightly reduced, sawtooth (square) shaped | Reduced |
Photopic b-wave |
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Only a few conditions may initially be confused with the X-linked form of congenital stationary night blindness (CSNB). Table 4. Disorders to Consider in the Differential Diagnosis of X-Linked Congenital Stationary Night Blindness
Fundus1 | DiffDx Disorder | Gene(s) | MOI | Clinical Features of DiffDx Disorder |
|---|---|---|---|---|
Normal fundus | CSNB (non-X-linked) | See footnote 2. | ARAD | Most autosomal CSNB is clinically identical, w/exception of AD CSNB, Nougaret type. |
Genetic testing for CACNA1F is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Aland island eye disease. The disease remains an area of unmet medical need.
To establish the extent of disease in an individual diagnosed with X-linked congenital stationary night blindness (CSNB), the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Ophthalmologic examination
Electroretinography
Dark adaptation (optional)
Consultation with a clinical geneticist and/or genetic counselor
Coincident high myopia or hyperopia can be managed with glasses or contact lenses. Occasionally, a boy with X-linked CSNB may adopt a cosmetically unacceptable or functionally awkward head posture to dampen the degree of nystagmus in a particular position of gaze (the so-called "null point"). In some instances the position of gaze for the null point may be shifted to a better functional range by carefully planned strabismus surgery.
Regular (yearly) eye examinations are recommended with refraction at a young age to monitor for the development of myopia.
Reduced visual acuity and difficulties seeing at night may preclude driving a car or restrict the class of driving license.
For infants identified with high myopia, unusual head posture, or nystagmus and a family history of CSNB, ophthalmic examination and molecular genetic testing may confirm the diagnosis of CSNB, obviating the need for neuroimaging or clinical electrophysiologic testing under sedation or general anesthesia.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Reduced visual acuity and difficulties seeing at night may preclude driving a car or restrict the class of driving license.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
View trials for Aland island eye disease
Regular (yearly) eye examinations are recommended with refraction at a young age to monitor for the development of myopia.
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
Phenotype severity distribution: 6 always present features, 4 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Aland island eye disease.
4 publications have been identified in PubMed for Aland island eye disease. Research spans Case Report / Case Series (100%).
Duemler A (2025). [PMID: 40400241](https://pubmed.ncbi.nlm.nih.gov/40400241/). *Ophthalmic Genet*. [Case Report / Case Series]
Wen L (2025). [PMID: 39652271](https://pubmed.ncbi.nlm.nih.gov/39652271/). *Doc Ophthalmol*. [Case Report / Case Series]
Murati Calderon RA (2025). [PMID: 40390739](https://pubmed.ncbi.nlm.nih.gov/40390739/). *Cureus*. [Case Report / Case Series]
Li M (2025). [PMID: 41381383](https://pubmed.ncbi.nlm.nih.gov/41381383/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 6:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Aland island eye disease
Reduced |
Photopic OP | Lost, except for OP4 | All OPs are lost. |
30-Hz flicker | Normal / slightly reduced | Reduced w/double peak Note: Pupillary responses have been described in the literature and in textbooks as "paradoxic" (i.e., miosis of pupils when lights are turned off, as opposed to dilation). This description predates genotyping. |
OPN1MW | XL | Poor vision; Nystagmus | Abnormal color vision; Almost completely abolished photopic ERG contrasting w/normal or minimally affected scotopic ERG; Fundus exam in young males is normal; some males develop macular atrophy in late adulthood. FRMD7-related infantile nystagmus | — |
FRMD7 | XL | Poor vision; Nystagmus | Normal ERG; Normal VEP; Normal foveal contour | — |
Abnormal fundus | Ocular albinism type I (OMIM 300500) | — | — | — |
OA1 | XL | Poor vision; Nystagmus | Iris transillumination; Foveal hypoplasia; Heterozygous females have fundus signs (hypopigmentation of retinal pigment epithelium).4; Absence of selective in amplitude of b-wave on ERG; VEP responses show propensity for more crossing fibers than expected at level of chiasm. | — |
RS1 | XL | Visual acuity to same range as in XL CSNB | Fundus exam shows foveal schisis or foveal findings in virtually all affected males ~50% have areas of peripheral retinoschisis. Oguchi disease5 (OMIM 258100, 613411) | SAG |
GRK1 | AR | Non-progressive | Fundus has abnormal color that becomes normal w/prolonged dark adaptation (Mizuo phenomenon).6 Fundus albipunctatus7 (OMIM 136880) | RDH5 |
RLBP1 | ARAD | Non-progressive | Fundus shows discretely scattered white retinal dots. AD = autosomal dominant; AR = autosomal recessive; DiffDx = differential diagnosis; ERG = electroretinogram; MOI = mode of inheritance; VEP = visual evoked potential; XL = X-linked 1. X-linked CSNB is characterized by a normal fundus. | — |
Source: GeneReviews — "X-Linked Congenital Stationary Night Blindness"
AI-curated news mentioning Aland island eye disease
Updated Jul 20, 2026
Stargardt Disease. American Academy of Ophthalmology. Macula. American Academy of Ophthalmology. Vision Loss, Central. MedlinePlus. Stargardt macular degeneration. National Cancer Institute. Choroid. MedlinePlus. Choroideremia. National Organization of Rare Disorders. Choroideremia. U.S. Food & Drug Administration. FDA approves novel gene therapy to treat patients with a rare form of inherited ... Stargardt Disease. American Academy of Ophthalmology. Macula. American Academy of Ophthalmology. Vision Loss, Central. MedlinePlus. Stargardt macular degeneration. National Cancer Institute. Choroid. MedlinePlus. Choroideremia. National Organization of Rare Disorders. Choroideremia. U.S. Food & Drug Administration. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss. This gene is associated with several IRDs, including retinitis pigmentosa. Other therapies in development include medications that prevent the death of cells in the eyes and prosthetics that are implanted into the eye to restore vision. Sources: PreventBlindness.org. Eye Diseases & Con... + 13 · PreventBlindness.org. Eye Diseases & Conditions: Inherited Retinal Diseases. Why family medical history matters to the health of your eyes.How your genetics can affect your vision ... Get a look at the healthcare providers you may work with if you are living with an inherited retinal disease (IRD).The specialists and therapies that treat IRDs Keep in mind that this is a simplified explanation of this condition—there are more than 60 different genes that can be involved in the development of RP, there are numerous subtypes of RP, the disease can follow different patterns, and it can occur as a result of multiple other genetic disorders. It’s estimated that RP affects one out of every 3,000 or 4,000 people. This inherited retinal disease is the most common form of juvenile macular degeneration and symptoms typically begin in late childhood or young adulthood.